“I like working at Intellia because I am challenged to think creatively and collaboratively. It’s rewarding to know our efforts are making an impact toward our goal of developing potentially life-changing therapies.”
“My father-in-law, Ben – or as Pam calls him, Benny – lost his battle with AML far too soon, which makes me especially proud to work for a company that is striving to provide curative treatments for that disease, among others.”
“Benny had a way of making everything OK. I miss his smile.”
“Have you ever been in an environment full of intellectual people? Now combine that with CRISPR/Cas9. Greatness at full potential.”
“The thought that my efforts to advance our CRISPR technology give hope to patients suffering from life-threatening genetic diseases drives me to work every day.”
“I get up every day to show our kids that life doesn’t stop with a diagnosis.”
“Intellia provides the perfect combination of innovative science, great people and room for professional growth.”
Each one of us together for patients.
Using a modular approach, we optimize the necessary therapeutic components so they can be used and combined in our in vivo and ex vivo programs to develop product candidates addressing a broad range of diseases. As exemplified by our current programs, this approach will allow us and our partners to build a full-spectrum genome editing company, with a pipeline of products that can treat a broad range of genetic and oncological diseases.
As a pioneer in the development of CRISPR/Cas9-based therapies, we are rapidly moving our development candidates towards the clinic so we can make them available to patients suffering severe and life-threatening disorders.
Our company’s unique strengths include our CRISPR/Cas9 system improvements, modular lipid nanoparticle delivery system and our determined focus on product development.
